(Q43408115)

English

Antimicrobial activity and in vitro susceptibility test development for cefditoren against Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus species

scientific article published in June 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Antimicrobial activity and in vitro susceptibility test development for cefditoren against Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus species (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Haemophilus influenzae

object named as

Haemophilus influenzae

1 reference

based on heuristic

inferred from title

Moraxella catarrhalis

object named as

Moraxella catarrhalis

1 reference

based on heuristic

inferred from title

5

object named as

Jones RN

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Michael A. Pfaller

4

object named as

Pfaller MA

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

author name string

Johnson DM

1

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Biedenbach DJ

2

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Beach ML

3

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

publication date

1 June 2000

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Diagnostic Microbiology and Infectious Disease

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

37

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

99-105

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

In vitro activities of 22 beta-lactam antibiotics against penicillin-resistant and penicillin-susceptible viridans group streptococci isolated from blood

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900136-X

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro activity of a new cephalosporin ME-1206 compared with other agents.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900136-X

7 January 2021

based on heuristic

inferred from DOI database lookup

In-vitro activity of cefditoren against clinical isolates of penicillin-susceptible and resistant strains of Streptococcus pneumoniae, Haemophilus influenzae and Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900136-X

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro evaluation of a novel orally administered cephalosporin (Cefditoren) tested against 1249 recent clinical isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900136-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Cefditoren activity against nearly 1000 non-fastidious bacterial isolates and the development of in vitro susceptibility test methods.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900136-X

7 January 2021

based on heuristic

inferred from DOI database lookup

A 1994-95 survey of Haemophilus influenzae susceptibility to ten orally administered agents. A 187 clinical laboratory center sample in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900136-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of agar dilution, microdilution, E-test, and disk diffusion methods for testing activity of cefditoren against Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900136-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Inoculum effect and bactericidal activity of cefditoren and other antibiotics against Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900136-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Activities of RPR 106972 (a new oral streptogramin), cefditoren (a new oral cephalosporin), two new oxazolidinones (U-100592 and U-100766), and other oral and parenteral agents against 203 penicillin-susceptible and -resistant pneumococci.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900136-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Time-kill studies on susceptibility of nine penicillin-susceptible and -resistant pneumococci to cefditoren compared with nine other beta-lactams

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900136-X

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro and in vivo antibacterial activities of ME1207, a new oral cephalosporin

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900136-X

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro and in vivo antibacterial activities of CS-834, a new oral carbapenem.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900136-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0732-8893(00)00136-X

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43408115&oldid=1988210391"